Inhibition of sEH, which increases FFA epoxides, improves glucose homeostasis and cardiovascular health [4,5,6] and is proposed as an effective strategy to treat diabetes and cardiovascular diseases [1,7]. The gene discussed is EPHX2; the disease is cardiovascular disorder.